New Delhi, June 23 -- Diagnostic stocks including Metropolis Healthcare, Dr Lal PathLabs, Krsnaa Diagnostics, and Thyrocare Technologies came under pressure during Monday's trade (June 23), falling up to 3% intraday as investor sentiment turned cautious after Amazon launched home diagnostic services, intensifying competition in India's $15 billion diagnostics market.

On Sunday, Amazon India announced the launch of Amazon Diagnostics - an at-home service that allows customers to book lab tests, schedule and track appointments, and access digital reports via the Amazon app - marking an expansion of its medical offerings beyond online pharmacy and teleconsultations.

(more to come)

Published by HT Digital Content Services with permission f...